LivaNova PLC (LIA)
FSX
Closed
Aug 24, 2026
Day's Range
66.5052 wk Range
42.80Overview - LIA - LivaNova PLC
Key Statistics
Valuation
Enterprise Value
3.01B
P/E (Trailing)
‪23.10‬
P/E (Forward)
‪27.01‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪2.50‬
Price / Book
‪3.21‬
EV / EBITDA
‪13.16‬
Profitability
Gross Margin
‪70.06%‬
Profit Margin
‪12.81%‬
Operating Margin
‪15.51%‬
Return on Assets
‪5.22%‬
Return on Equity
‪15.40%‬
Ownership
Shares Outstanding
55.05M
Float
54.82M
Held by Insiders
‪0.41%‬
Held by Institutions
‪113.18%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪69.81‬
200-Day Avg
‪59.00‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - LIA - LivaNova PLC
Peers - LIA - LivaNova PLC
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
- LIAFSXLivaNova PLC3.82BMarket Cap+32.24%52-week change23.21P/E (Trailing)‪12.81%‬Profit Margin
- ABLFSXAbbott Laboratories168.26BMarket Cap-15.82%52-week change36.83P/E (Trailing)‪11.64%‬Profit Margin
- ABL0FSXAbbott Laboratories CDR164.09BMarket Cap-14.29%52-week change36.18P/E (Trailing)‪11.64%‬Profit Margin
- CFXFSXCapital One Financial Corporation116.31BMarket Cap+0.84%52-week change12.20P/E (Trailing)‪21.86%‬Profit Margin
- SYKFSXStryker Corporation107.66BMarket Cap-18.85%52-week change34.02P/E (Trailing)‪14.43%‬Profit Margin
- 2M6FSXMedtronic plc102.37BMarket Cap+1.29%52-week change25.07P/E (Trailing)‪13.20%‬Profit Margin
- ASGFSXAssicurazioni Generali S.p.A.64.98BMarket Cap+19.66%52-week change14.57P/E (Trailing)‪7.68%‬Profit Margin
Profile Summary - LIA - LivaNova PLC
About
LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
